Cargando…
Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial
Anxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD biomarkers. Primary results of the trial reported tha...
Autores principales: | Blumenthal, James A., Smith, Patrick J., Jiang, Wei, Hinderliter, Alan, Watkins, Lana L., Hoffman, Benson M., Kraus, William E., Mabe, Stephanie, Liao, Lawrence, Davidson, Jonathan, Sherwood, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604196/ https://www.ncbi.nlm.nih.gov/pubmed/36286272 http://dx.doi.org/10.3390/jcdd9100320 |
Ejemplares similares
-
Association of Anxiety and Depression With All‐Cause Mortality in Individuals With Coronary Heart Disease
por: Watkins, Lana L., et al.
Publicado: (2013) -
Association between normal or mildly reduced kidney function, cardiovascular risk and biomarkers for atherosclerosis: results from the ENCORE trial
por: Tyson, Crystal C., et al.
Publicado: (2017) -
The Influence of Endothelial Function and Myocardial Ischemia on Peak Oxygen Consumption in Patients with Coronary Artery Disease
por: Bacon, Simon L., et al.
Publicado: (2012) -
Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
por: Kang, Hee-Ju, et al.
Publicado: (2017) -
Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)